Literature DB >> 1569337

Streptococcal toxic shock syndrome: synthesis of tumor necrosis factor and interleukin-1 by monocytes stimulated with pyrogenic exotoxin A and streptolysin O.

S P Hackett1, D L Stevens.   

Abstract

Previous studies have found that 80% of strains isolated from patients with the streptococcal toxic shock syndrome produce pyrogenic exotoxin A (SPEA) and 100% produced streptolysin O (SLO). To elucidate the cellular mechanisms contributing to shock, human monocytes were stimulated with SPEA (0.1-10 micrograms/10(6) monocytes) or SLO (0.2-2.5 hemolytic units/10(6) monocytes), and production of tumor necrosis factor (TNF)-alpha and interleukin (IL)-1 beta was measured at 24, 48, and 72 h. SPEA and SLO were potent inducers of TNF alpha, with maximum production occurring at 72 h for SPEA and at 48 h for SLO (1067 and 687 pg/ml, respectively). In contrast, IL-1 beta production was greater for SLO than for SPEA (557 vs. 258 pg/ml). In addition, the effects of SPEA and SLO together were synergistic in terms of monocyte IL-1 beta production: SPEA, 193 pg/ml; SLO, 452 pg/ml; SPEA plus SLO, 799 pg/ml. These findings suggest TNF alpha and IL-1 beta are important candidates for mediating shock in severe streptococcal infections.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1569337     DOI: 10.1093/infdis/165.5.879

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  51 in total

1.  Induction of gamma interferon and nitric oxide by truncated pneumolysin that lacks pore-forming activity.

Authors:  Hisashi Baba; Ikuo Kawamura; Chikara Kohda; Takamasa Nomura; Yutaka Ito; Terumi Kimoto; Isao Watanabe; Satoshi Ichiyama; Masao Mitsuyama
Journal:  Infect Immun       Date:  2002-01       Impact factor: 3.441

2.  Pyrogenicity and cytokine-inducing properties of Streptococcus pyogenes superantigens: comparative study of streptococcal mitogenic exotoxin Z and pyrogenic exotoxin A.

Authors:  H Müller-Alouf; T Proft; T M Zollner; D Gerlach; E Champagne; P Desreumaux; C Fitting; C Geoffroy-Fauvet; J E Alouf; J M Cavaillon
Journal:  Infect Immun       Date:  2001-06       Impact factor: 3.441

Review 3.  Necrotising fasciitis.

Authors:  Saiidy Hasham; Paolo Matteucci; Paul R W Stanley; Nick B Hart
Journal:  BMJ       Date:  2005-04-09

Review 4.  Necrotising fasciitis: a new management algorithm based on clinical classification.

Authors:  Paul S Carter; Paul E Banwell
Journal:  Int Wound J       Date:  2004-09       Impact factor: 3.315

5.  Immune cell subsets in necrotizing fasciitis: an immunohistochemical analysis.

Authors:  A J Saenz; A F Koreishi; A E Rosenberg; R L Kradin
Journal:  Virchows Arch       Date:  2009-06-16       Impact factor: 4.064

6.  Streptococcal pyrogenic exotoxin F (SpeF) causes permeabilization of lung blood vessels.

Authors:  M Matsumoto; N Ishikawa; M Saito; K Shibayama; T Horii; K Sato; M Ohta
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

7.  Mutational analysis of superantigen activity responsible for the induction of skin erythema by streptococcal pyrogenic exotoxin C.

Authors:  J Yamaoka; E Nakamura; Y Takeda; S Imamura; N Minato
Journal:  Infect Immun       Date:  1998-10       Impact factor: 3.441

8.  Superantigenic properties of the group A streptococcal exotoxin SpeF (MF).

Authors:  A Norrby-Teglund; D Newton; M Kotb; S E Holm; M Norgren
Journal:  Infect Immun       Date:  1994-12       Impact factor: 3.441

9.  Cleavage of interleukin 1 beta (IL-1 beta) precursor to produce active IL-1 beta by a conserved extracellular cysteine protease from Streptococcus pyogenes.

Authors:  V Kapur; M W Majesky; L L Li; R A Black; J M Musser
Journal:  Proc Natl Acad Sci U S A       Date:  1993-08-15       Impact factor: 11.205

10.  Streptococcal cysteine protease augments lung injury induced by products of group A streptococci.

Authors:  T P Shanley; D Schrier; V Kapur; M Kehoe; J M Musser; P A Ward
Journal:  Infect Immun       Date:  1996-03       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.